Retamal P
Servicio B, Instituto Psiquiátrico, Santiago de Chile.
Rev Med Chil. 1990 Jun;118(6):679-85.
This is a review article on neuroleptic malignant syndrome. Clinical manifestations and differential diagnosis are discussed. Treatment is based on suppression of the drug and administration of bromocriptine and dantrolene. After recovery, neuroleptics should be withheld or a drug with low dopaminergic blocking effect would be selected.